PROPRANOLOL
Myocardial Injury After Noncardiac Surgery (MINS)
Chang-Ik YoonSmall moleculePhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 50/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Myocardial Injury After Noncardiac Surgery (MINS) cohort.
Same molecule, other indications
PROPRANOLOL is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →